Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Rapt Therapeutics, Inc. (RAPT) since 2019 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Rapt Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1673772.
Total stock buying since 2019: $48,163,018.
Total stock sales since 2019: $81,961,113.
Total stock option exercises since 2019: $1,233,073.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 0 | $0 | 898 | $20,456 | 0 | $0 |
| 2023 | 5,000 | $96,540 | 29,742 | $698,103 | 10,300 | $77,040 |
| 2022 | 2,538,550 | $27,132,528 | 43,810 | $1,021,424 | 23,634 | $179,716 |
| 2021 | 6,600 | $180,807 | 453,595 | $15,462,017 | 50,226 | $491,403 |
| 2020 | 17,600 | $357,943 | 4,448,756 | $64,759,113 | 71,277 | $484,914 |
| 2019 | 1,699,600 | $20,395,200 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-01 | 0 | $0 | 898 | $20,456 | 0 | $0 |
| 2023-12 | 0 | $0 | 2,500 | $54,200 | 8,000 | $49,440 |
| 2023-11 | 0 | $0 | 1,500 | $20,580 | 0 | $0 |
| 2023-10 | 0 | $0 | 2,500 | $39,425 | 0 | $0 |
| 2023-08 | 0 | $0 | 2,500 | $47,300 | 0 | $0 |
| 2023-07 | 0 | $0 | 0 | $0 | 460 | $5,520 |
| 2023-06 | 0 | $0 | 0 | $0 | 920 | $11,040 |
| 2023-04 | 0 | $0 | 5,000 | $94,400 | 460 | $5,520 |
| 2023-03 | 5,000 | $96,540 | 5,000 | $148,100 | 460 | $5,520 |
| 2023-01 | 0 | $0 | 10,742 | $294,098 | 0 | $0 |
| 2022-12 | 0 | $0 | 5,000 | $90,150 | 0 | $0 |
| 2022-11 | 0 | $0 | 10,000 | $200,950 | 0 | $0 |
| 2022-10 | 0 | $0 | 2,000 | $43,040 | 807 | $7,384 |
| 2022-09 | 0 | $0 | 0 | $0 | 808 | $7,393 |
| 2022-08 | 0 | $0 | 2,500 | $70,325 | 807 | $7,384 |
| 2022-07 | 0 | $0 | 2,000 | $39,900 | 2,422 | $22,161 |
| 2022-05 | 2,538,550 | $27,132,528 | 720 | $10,836 | 0 | $0 |
| 2022-04 | 0 | $0 | 5,647 | $129,893 | 4,262 | $31,776 |
| 2022-03 | 0 | $0 | 2,648 | $63,313 | 2,648 | $16,364 |
| 2022-02 | 0 | $0 | 5,647 | $115,848 | 3,454 | $23,742 |
| 2022-01 | 0 | $0 | 7,648 | $257,169 | 8,426 | $63,512 |
| 2021-12 | 0 | $0 | 5,647 | $178,519 | 2,647 | $16,676 |
| 2021-11 | 0 | $0 | 2,648 | $94,507 | 2,648 | $16,682 |
| 2021-10 | 900 | $27,226 | 5,647 | $170,544 | 2,647 | $16,358 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-01-05 | Brockstedt Dirk G. (CHIEF SCIENTIFIC OFFICER) | Sale | 898 | 22.78 | 20,456 |
| 2023-12-29 | Brockstedt Dirk G. (Chief Scientific Officer) | Option Ex | 8,000 | 6.18 | 49,440 |
| 2023-12-21 | Ho William (Chief Medical Officer) | Sale | 2,500 | 21.68 | 54,200 |
| 2023-11-28 | Ho William (Chief Medical Officer) | Sale | 1,500 | 13.72 | 20,580 |
| 2023-10-03 | Ho William (Chief Medical Officer) | Sale | 2,500 | 15.77 | 39,425 |
| 2023-08-18 | Ho William (Chief Medical Officer) | Sale | 2,500 | 18.92 | 47,300 |
| 2023-07-28 | Ho William (Chief Medical Officer) | Option Ex | 460 | 12.00 | 5,520 |
| 2023-06-23 | Ho William (Chief Medical Officer) | Option Ex | 920 | 12.00 | 11,040 |
| 2023-04-19 | Ho William (Chief Medical Officer) | Sale | 5,000 | 18.88 | 94,400 |
| 2023-04-13 | Ho William (Chief Medical Officer) | Option Ex | 460 | 12.00 | 5,520 |
| 2023-03-14 | Robbins Wendye (Director) | Buy | 5,000 | 19.31 | 96,540 |
| 2023-03-07 | Ho William (Chief Medical Officer) | Sale | 5,000 | 29.62 | 148,100 |
| 2023-03-03 | Ho William (Chief Medical Officer) | Option Ex | 460 | 12.00 | 5,520 |
| 2023-01-24 | Ho William (Chief Medical Officer) | Sale | 5,000 | 30.00 | 150,000 |
| 2023-01-19 | Ho William (Chief Medical Officer) | Sale | 5,000 | 25.56 | 127,800 |
| 2023-01-05 | Brockstedt Dirk G. (Chief Scientific Officer) | Sale | 742 | 21.97 | 16,298 |
| 2022-12-29 | Ho William (Chief Medical Officer) | Sale | 5,000 | 18.03 | 90,150 |
| 2022-11-28 | Ho William (Chief Medical Officer) | Sale | 5,000 | 17.87 | 89,350 |
| 2022-11-02 | Ho William (Chief Medical Officer) | Sale | 5,000 | 22.32 | 111,600 |
| 2022-10-13 | Ho William (Chief Medical Officer) | Sale | 2,000 | 21.52 | 43,040 |
| 2022-10-03 | Ho William (Chief Medical Officer) | Option Ex | 807 | 9.15 | 7,384 |
| 2022-09-01 | Ho William (Chief Medical Officer) | Option Ex | 808 | 9.15 | 7,393 |
| 2022-08-30 | Ho William (Chief Medical Officer) | Sale | 2,500 | 28.13 | 70,325 |
| 2022-08-12 | Ho William (Chief Medical Officer) | Option Ex | 807 | 9.15 | 7,384 |
| 2022-07-11 | Ho William (Chief Medical Officer) | Sale | 2,000 | 19.95 | 39,900 |
| 2022-07-11 | Ho William (Chief Medical Officer) | Option Ex | 2,422 | 9.15 | 22,161 |
| 2022-05-24 | Tcg Iv Gp, Llc (10% Owner) | Buy | 16,314 | 12.00 | 195,800 |
| 2022-05-23 | Tcg Iv Gp, Llc (10% Owner) | Buy | 10,236 | 12.50 | 127,939 |
| 2022-05-10 | Column Group Llc (10% Owner) | Buy | 1,250,000 | 10.67 | 13,340,000 |
| 2022-05-10 | Tcg Iv Gp, Llc (10% Owner) | Buy | 1,250,000 | 10.67 | 13,340,000 |
| 2022-05-10 | Robbins Wendye | Buy | 7,000 | 10.88 | 76,139 |
| 2022-05-10 | Young Rodney Kb (Chief Financial Officer) | Buy | 5,000 | 10.53 | 52,650 |
| 2022-05-04 | Brockstedt Dirk G. (Chief Scientific Officer) | Sale | 720 | 15.05 | 10,836 |
| 2022-04-11 | Brockstedt Dirk G. (Chief Scientific Officer) | Sale | 2,647 | 23.05 | 61,013 |
| 2022-04-11 | Brockstedt Dirk G. (Chief Scientific Officer) | Option Ex | 2,647 | 6.18 | 16,358 |
| 2022-04-11 | Ho William (Chief Medical Officer) | Option Ex | 920 | 12.00 | 11,040 |
| 2022-04-06 | Ho William (Chief Medical Officer) | Sale | 3,000 | 22.96 | 68,880 |
| 2022-04-04 | Ho William (Chief Medical Officer) | Option Ex | 695 | 6.30 | 4,378 |
| 2022-03-11 | Brockstedt Dirk G. (Chief Scientific Officer) | Sale | 2,648 | 23.91 | 63,313 |
| 2022-03-11 | Brockstedt Dirk G. (Chief Scientific Officer) | Option Ex | 2,648 | 6.18 | 16,364 |
| 2022-02-28 | Ho William (Chief Medical Officer) | Sale | 3,000 | 18.79 | 56,370 |
| 2022-02-11 | Brockstedt Dirk G. (Chief Scientific Officer) | Sale | 2,647 | 22.47 | 59,478 |
| 2022-02-11 | Brockstedt Dirk G. (Chief Scientific Officer) | Option Ex | 2,647 | 6.18 | 16,358 |
| 2022-02-08 | Ho William (Chief Medical Officer) | Option Ex | 807 | 9.15 | 7,384 |
| 2022-01-13 | Ho William (Chief Medical Officer) | Sale | 3,000 | 30.67 | 92,010 |
| 2022-01-11 | Brockstedt Dirk G. (Chief Scientific Officer) | Sale | 2,648 | 32.16 | 85,159 |
| 2022-01-11 | Brockstedt Dirk G. (Chief Scientific Officer) | Option Ex | 2,648 | 6.18 | 16,364 |
| 2022-01-05 | Ho William (Chief Medical Officer) | Sale | 2,000 | 40.00 | 80,000 |
| 2022-01-04 | Ho William (Chief Medical Officer) | Option Ex | 5,778 | 8.16 | 47,148 |
| 2021-12-10 | Brockstedt Dirk G. (Chief Scientific Officer) | Sale | 2,647 | 30.88 | 81,739 |
| 2021-12-10 | Brockstedt Dirk G. (Chief Scientific Officer) | Option Ex | 2,647 | 6.30 | 16,676 |
| 2021-12-03 | Ho William (Chief Medical Officer) | Sale | 3,000 | 32.26 | 96,780 |
| 2021-11-11 | Brockstedt Dirk G. (Chief Scientific Officer) | Sale | 2,648 | 35.69 | 94,507 |
| 2021-11-11 | Brockstedt Dirk G. (Chief Scientific Officer) | Option Ex | 2,648 | 6.30 | 16,682 |
| 2021-10-18 | Robbins Wendye | Buy | 500 | 30.70 | 15,350 |
| 2021-10-13 | Robbins Wendye | Buy | 400 | 29.69 | 11,876 |
| 2021-10-13 | Ho William (Chief Medical Officer) | Sale | 3,000 | 29.69 | 89,070 |
| 2021-10-11 | Brockstedt Dirk G. (Chief Scientific Officer) | Sale | 2,647 | 30.78 | 81,474 |
| 2021-10-11 | Brockstedt Dirk G. (Chief Scientific Officer) | Option Ex | 2,647 | 6.18 | 16,358 |
| 2021-09-27 | Column Group Llc (10% Owner) | Sale | 9,239 | 34.80 | 321,489 |
| 2021-09-27 | Column Group Llc (10% Owner) | Option Ex | 9,239 | 23.26 | 214,871 |
| 2021-09-20 | Ho William (Chief Medical Officer) | Sale | 2,000 | 40.00 | 80,000 |
| 2021-09-17 | Ho William (Chief Medical Officer) | Sale | 2,000 | 38.92 | 77,848 |
| 2021-09-15 | Column Group Llc (10% Owner) | Sale | 33,535 | 37.45 | 1,255,986 |
| 2021-09-14 | Column Group Llc (10% Owner) | Sale | 147,676 | 36.63 | 5,409,371 |
| 2021-09-13 | Column Group Llc (10% Owner) | Sale | 14,317 | 35.27 | 504,946 |
| 2021-09-10 | Column Group Llc (10% Owner) | Sale | 21,738 | 35.19 | 765,003 |
| 2021-09-10 | Brockstedt Dirk G. (Chief Scientific Officer) | Sale | 2,648 | 35.78 | 94,745 |
| 2021-09-10 | Brockstedt Dirk G. (Chief Scientific Officer) | Option Ex | 2,648 | 6.18 | 16,364 |
| 2021-09-08 | Ho William (Chief Medical Officer) | Sale | 3,000 | 36.04 | 108,120 |
| 2021-09-02 | Column Group Llc (10% Owner) | Sale | 37,101 | 35.43 | 1,314,562 |
| 2021-09-01 | Column Group Llc (10% Owner) | Sale | 31,749 | 35.23 | 1,118,549 |
| 2021-08-24 | Column Group Llc (10% Owner) | Sale | 22,867 | 31.30 | 715,805 |
| 2021-08-24 | Robbins Wendye | Buy | 525 | 30.91 | 16,225 |
| 2021-08-23 | Column Group Llc (10% Owner) | Sale | 68,340 | 31.57 | 2,157,630 |
| 2021-08-23 | Robbins Wendye | Buy | 1,475 | 31.42 | 46,338 |
| 2021-08-20 | Column Group Llc (10% Owner) | Sale | 4,539 | 30.08 | 136,533 |
| 2021-08-20 | Robbins Wendye | Buy | 600 | 29.64 | 17,785 |
| 2021-08-16 | Ho William (Chief Medical Officer) | Sale | 1,000 | 32.07 | 32,070 |
| 2021-08-11 | Brockstedt Dirk G. (Chief Scientific Officer) | Sale | 2,647 | 31.19 | 82,559 |
| 2021-08-11 | Brockstedt Dirk G. (Chief Scientific Officer) | Option Ex | 2,647 | 6.18 | 16,358 |
| 2021-08-06 | Ho William (Chief Medical Officer) | Option Ex | 3,690 | 12.00 | 44,280 |
| 2021-08-04 | Ho William (Chief Medical Officer) | Option Ex | 694 | 6.24 | 4,330 |
| 2021-08-02 | Ho William (Chief Medical Officer) | Sale | 1,000 | 30.52 | 30,520 |
| 2021-07-23 | Ho William (Chief Medical Officer) | Option Ex | 8,193 | 6.24 | 51,124 |
| 2021-07-15 | Ho William (Chief Medical Officer) | Sale | 1,000 | 30.23 | 30,230 |
| 2021-07-12 | Brockstedt Dirk G. (Chief Scientific Officer) | Sale | 2,648 | 33.53 | 88,787 |
| 2021-07-12 | Brockstedt Dirk G. (Chief Scientific Officer) | Option Ex | 2,648 | 6.18 | 16,364 |
| 2021-07-07 | Robbins Wendye | Buy | 1,000 | 30.18 | 30,175 |
| 2021-06-15 | Ho William (Chief Medical Officer) | Sale | 1,000 | 43.26 | 43,260 |
| 2021-06-14 | Ho William (Chief Medical Officer) | Sale | 2,000 | 40.00 | 80,000 |
| 2021-06-01 | Ho William (Chief Medical Officer) | Sale | 1,000 | 19.50 | 19,500 |
| 2021-05-17 | Ho William (Chief Medical Officer) | Sale | 1,000 | 19.87 | 19,870 |
| 2021-05-11 | Brockstedt Dirk G. (Chief Scientific Officer) | Sale | 2,648 | 18.19 | 48,167 |
| 2021-05-11 | Brockstedt Dirk G. (Chief Scientific Officer) | Option Ex | 2,648 | 6.18 | 16,364 |
| 2021-05-05 | Brockstedt Dirk G. (Chief Scientific Officer) | Sale | 2,084 | 21.56 | 44,931 |
| 2021-05-03 | Ho William (Chief Medical Officer) | Sale | 1,000 | 22.04 | 22,040 |
| 2021-04-15 | Ho William (Chief Medical Officer) | Sale | 1,000 | 21.14 | 21,140 |
| 2021-04-13 | Robbins Wendye | Buy | 700 | 19.45 | 13,615 |
| 2021-04-09 | Robbins Wendye | Buy | 1,400 | 21.03 | 29,443 |
| 2021-04-01 | Ho William (Chief Medical Officer) | Sale | 1,000 | 22.66 | 22,660 |
| 2021-03-15 | Ho William (Chief Medical Officer) | Sale | 1,000 | 21.91 | 21,910 |
| 2021-03-01 | Ho William (Chief Medical Officer) | Sale | 1,000 | 18.60 | 18,600 |
| 2021-02-16 | Brockstedt Dirk G. (Chief Scientific Officer) | Sale | 9,877 | 21.22 | 209,589 |
| 2021-02-16 | Brockstedt Dirk G. (Chief Scientific Officer) | Option Ex | 9,877 | 6.24 | 61,632 |
| 2021-02-16 | Ho William (Chief Medical Officer) | Sale | 1,000 | 21.81 | 21,810 |
| 2021-02-01 | Ho William (Chief Medical Officer) | Sale | 1,000 | 19.99 | 19,990 |
| 2021-01-15 | Ho William (Chief Medical Officer) | Sale | 1,000 | 21.05 | 21,050 |
| 2021-01-06 | Brockstedt Dirk G. (Chief Scientific Officer) | Sale | 1,179 | 19.68 | 23,202 |
| 2021-01-05 | Brockstedt Dirk G. (Chief Scientific Officer) | Sale | 821 | 19.76 | 16,225 |
| 2021-01-04 | Ho William (Chief Medical Officer) | Sale | 1,000 | 19.75 | 19,750 |
| 2020-12-30 | Brockstedt Dirk G. (Chief Scientific Officer) | Option Ex | 9,300 | 6.18 | 57,474 |
| 2020-12-15 | Ho William (Chief Medical Officer) | Sale | 1,000 | 24.55 | 24,550 |
| 2020-12-01 | Ho William (Chief Medical Officer) | Sale | 1,000 | 21.83 | 21,830 |
| 2020-11-19 | Robbins Wendye | Buy | 1,000 | 16.09 | 16,085 |
| 2020-11-19 | Rieflin William Jl | Buy | 10,000 | 16.22 | 162,200 |
| 2020-11-16 | Brockstedt Dirk G. (Chief Scientific Officer) | Sale | 9,877 | 17.01 | 168,007 |
| 2020-11-16 | Brockstedt Dirk G. (Chief Scientific Officer) | Option Ex | 9,877 | 6.24 | 61,632 |
| 2020-11-16 | Ho William (Chief Medical Officer) | Sale | 1,000 | 20.25 | 20,250 |
| 2020-11-16 | Ho William (Chief Medical Officer) | Option Ex | 8,356 | 6.24 | 52,141 |
| 2020-11-02 | Lam Karen C (VP, Finance and Controller) | Sale | 2,022 | 28.14 | 56,899 |
| 2020-11-02 | Brockstedt Dirk G. (Chief Scientific Officer) | Sale | 1,910 | 28.06 | 53,594 |
| 2020-11-02 | Ho William (Chief Medical Officer) | Sale | 1,000 | 28.06 | 28,060 |
| 2020-10-15 | Ho William (Chief Medical Officer) | Sale | 1,000 | 35.76 | 35,760 |
| 2020-10-12 | Wong Brian Russell (President and CEO) | Sale | 20,000 | 40.05 | 801,040 |
| 2020-10-12 | Ho William (Chief Medical Officer) | Sale | 2,000 | 40.20 | 80,400 |
| 2020-10-01 | Ho William (Chief Medical Officer) | Sale | 1,000 | 31.18 | 31,180 |
| 2020-09-28 | Robbins Wendye | Buy | 500 | 28.68 | 14,337 |
| 2020-09-24 | Robbins Wendye | Buy | 200 | 28.00 | 5,600 |
| 2020-09-24 | Ho William (Chief Medical Officer) | Option Ex | 2,200 | 6.18 | 13,596 |
| 2020-09-23 | Robbins Wendye | Buy | 400 | 29.30 | 11,719 |
| 2020-09-23 | Wong Brian Russell (President and CEO) | Buy | 2,000 | 30.06 | 60,120 |
| 2020-09-22 | Svennilson Peter (Director) | Sale | 608,000 | 30.85 | 18,756,800 |
| 2020-09-22 | Goeddel David V (Other) | Sale | 608,000 | 30.85 | 18,756,800 |
| 2020-09-15 | Ho William (Chief Medical Officer) | Sale | 1,000 | 36.14 | 36,140 |
| 2020-09-01 | Ho William (Chief Medical Officer) | Sale | 1,000 | 26.24 | 26,240 |
| 2020-08-17 | Brockstedt Dirk G. (Chief Scientific Officer) | Sale | 9,877 | 23.60 | 233,097 |
| 2020-08-17 | Brockstedt Dirk G. (Chief Scientific Officer) | Option Ex | 9,877 | 6.18 | 61,039 |
| 2020-08-17 | Svennilson Peter (Director) | Sale | 538,654 | 22.75 | 12,254,378 |
| 2020-08-17 | Ho William (Chief Medical Officer) | Sale | 1,000 | 24.76 | 24,760 |
| 2020-08-17 | Goeddel David V (Other) | Sale | 538,654 | 22.75 | 12,254,378 |
| 2020-08-03 | Ho William (Chief Medical Officer) | Sale | 1,000 | 21.54 | 21,540 |
| 2020-07-24 | Robbins Wendye (Director) | Buy | 900 | 22.50 | 20,250 |
| 2020-07-15 | Ho William (Chief Medical Officer) | Sale | 1,000 | 28.76 | 28,760 |
| 2020-07-01 | Robbins Wendye (Director) | Buy | 1,000 | 26.40 | 26,400 |
| 2020-07-01 | Ho William (Chief Medical Officer) | Sale | 1,000 | 28.61 | 28,610 |
| 2020-06-29 | Robbins Wendye (Director) | Buy | 1,600 | 25.77 | 41,232 |
| 2020-06-25 | Lam Karen C (VP, Finance & Controller) | Sale | 875 | 35.00 | 30,625 |
| 2020-06-25 | Giordano Michael F (Director) | Sale | 19,013 | 33.37 | 634,463 |
| 2020-06-25 | Giordano Michael F (Director) | Option Ex | 19,013 | 9.09 | 172,828 |
| 2020-06-15 | Ho William (Chief Medical Officer) | Sale | 1,000 | 20.95 | 20,950 |
| 2020-06-01 | Ho William (Chief Medical Officer) | Sale | 1,000 | 18.50 | 18,500 |
| 2020-05-26 | Guthart Leo | Sale | 2,056,666 | .00 | 0 |
| 2020-05-22 | Ho William (Chief Medical Officer) | Sale | 7,500 | 18.02 | 135,150 |
| 2020-05-15 | Brockstedt Dirk G. (Chief Scientific Officer) | Sale | 9,877 | 15.00 | 148,155 |
| 2020-05-15 | Brockstedt Dirk G. (Chief Scientific Officer) | Option Ex | 9,877 | 6.18 | 61,039 |
| 2020-05-12 | Lam Karen C (VP, Finance & Controller) | Option Ex | 2,777 | 1.86 | 5,165 |
| 2020-05-07 | Lam Karen C (VP, Finance & Controller) | Sale | 1,831 | 15.40 | 28,197 |
| 2019-11-04 | Robbins Wendye (Director) | Buy | 1,600 | 12.00 | 19,200 |
| 2019-11-04 | Column Group Ii Management, Lp (10% Owner) | Buy | 625,000 | 12.00 | 7,500,000 |
| 2019-11-04 | Wong Brian Russell (President and CEO) | Buy | 25,000 | 12.00 | 300,000 |
| 2019-11-04 | Guthart Leo | Buy | 415,000 | 12.00 | 4,980,000 |
| 2019-11-04 | Rieflin William Jl (Director) | Buy | 8,000 | 12.00 | 96,000 |
| 2019-11-04 | Goeddel David V (Director) | Buy | 625,000 | 12.00 | 7,500,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of RAPT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Rapt Therapeutics, Inc. (symbol RAPT, CIK number 1673772) see the Securities and Exchange Commission (SEC) website.